Reports for GLAXOSMITHKLINE INC
Company Name
GLAXOSMITHKLINE INC
Totals |
||
Shortage reports |
322 |
|
| Actual shortage: | 10 (3%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 6 (2%) | |
| Resolved: | 306 (95%) | |
Discontinuation Reports |
56 |
|
| To be discontinued: | 2 (4%) | |
| Discontinued: | 54 (96%) | |
| Reversed: | 0 (0%) | |
Late reports |
4 (1%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| SYNFLORIX | 3MCG 3MCG 3MCG 1MCG 3MCG 1MCG 1MCG 1MCG 1MCG 1MCG 1MCG | SUSPENSION | Resolved | 2018-07-13 | 2018-08-02 | 55709 |
| CERVARIX | 20MCG 20MCG | SUSPENSION | Resolved | 2018-04-13 | 2018-11-15 | 45668 |
| BEXSERO | 50MCG 50MCG 50MCG 25MCG | SUSPENSION | Resolved | 2018-07-13 | 2018-08-08 | 55706 |
| BEXSERO | 50MCG 50MCG 50MCG 25MCG | SUSPENSION | Resolved | 2018-08-31 | 2018-09-06 | 59702 |
| BEXSERO | 50MCG 50MCG 50MCG 25MCG | SUSPENSION | Resolved | 2018-10-05 | 2018-10-31 | 63383 |
| BEXSERO | 50MCG 50MCG 50MCG 25MCG | SUSPENSION | Resolved | 2019-02-13 | 2019-03-22 | 75721 |
| BEXSERO | 50MCG 50MCG 50MCG 25MCG | SUSPENSION | Resolved | 2019-02-13 | 2019-03-21 | 75724 |
| BEXSERO | 25MCG 50MCG 50MCG 50MCG | SUSPENSION | Resolved | 2024-01-12 | 2024-02-10 | 215839 |
| SHINGRIX | 50MCG | SUSPENSION | Resolved | 2018-04-13 | 2018-06-08 | 45716 |
| SHINGRIX | 50MCG | SUSPENSION | Resolved | 2018-08-24 | 2020-06-18 | 59142 |
| SHINGRIX | 50MCG | SUSPENSION | Resolved | 2018-08-24 | 2020-06-18 | 59145 |
| SHINGRIX | 50MCG | SUSPENSION | Resolved | 2022-03-17 | 2022-09-09 | 156847 |
| SHINGRIX | 50MCG | SUSPENSION | Resolved | 2022-09-30 | 2022-10-13 | 170539 |
| SHINGRIX | 50MCG | SUSPENSION | Resolved | 2023-06-08 | 2023-07-15 | 193889 |
| SHINGRIX | 50MCG | SUSPENSION | Actual shortage | 2024-04-24 | 2024-04-25 | 226055 |
| ENGERIX-B | 10MCG | SUSPENSION | Resolved | 2021-06-28 | 2021-07-20 | 141615 |
| ENGERIX-B | 10MCG | SUSPENSION | Resolved | 2022-03-15 | 2022-04-13 | 156738 |
| ENGERIX-B | 10MCG | SUSPENSION | Resolved | 2022-10-07 | 2022-10-13 | 171261 |
| ENGERIX-B | 10MCG | SUSPENSION | Resolved | 2023-03-10 | 2023-04-28 | 186642 |
| ENGERIX-B | 20MCG | SUSPENSION | Resolved | 2020-02-03 | 2020-03-25 | 105174 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| REQUIP | 5MG | TABLET | Discontinued | 2017-09-19 | 2018-03-15 | 22603 |
| ZANTAC | 150MG | TABLET | Discontinued | 2017-09-19 | 2017-09-19 | 22611 |
| ZANTAC | 300MG | TABLET | Discontinued | 2017-09-19 | 2017-09-19 | 22614 |
| AVANDIA | 2MG | TABLET | Discontinued | 2020-04-27 | 2020-09-01 | 113311 |
| AVANDIA | 4MG | TABLET | Discontinued | 2020-04-27 | 2020-12-11 | 113314 |
| AVANDIA | 8MG | TABLET | Discontinued | 2020-04-27 | 2020-04-27 | 113317 |
| CEFTIN - TAB 250MG | 250MG | TABLET | Discontinued | 2020-07-24 | 2020-07-24 | 121046 |
| CEFTIN - TAB 500MG | 500MG | TABLET | Discontinued | 2020-07-24 | 2020-07-24 | 121049 |
| AMERGE | 1MG | TABLET | Discontinued | 2021-10-28 | 2022-08-09 | 148427 |
| AMERGE | 2.5MG | TABLET | Discontinued | 2021-10-28 | 2022-12-02 | 148430 |
| HEPTOVIR | 100MG | TABLET | Discontinued | 2022-05-13 | 2022-08-10 | 160500 |
| CLAVULIN 875 | 125MG 875MG | TABLET | Discontinued | 2024-01-18 | 2024-01-18 | 216509 |
| CLAVULIN 500 F TAB | 125MG 500MG | TABLET | Discontinued | 2024-02-02 | 2024-02-02 | 218240 |
| PAXIL TAB 10MG | 10MG | TABLET | To be discontinued | 2024-04-05 | 2024-04-05 | 224405 |
| PAXIL TAB 30MG | 30MG | TABLET | To be discontinued | 2024-04-05 | 2024-04-05 | 224430 |
| MESASAL | 500MG | TABLET (ENTERIC-COATED) | Discontinued | 2017-03-17 | 2017-03-24 | 3333 |